Fluent Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,458
Closed -$518K 101
2024
Q1
$518K Buy
+5,458
New +$506K 0.29% 55

Other funds holding XBI

Fluent Financial's XBI Position: Q2 2024 in Review

Fluent Financial sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2024, closing a stake of 5,458 shares — an estimated $518K sold.

Fluent Financial first reported a position in XBI in Q1 2024 and held it in 1 quarter. The position peaked at $518K in Q1 2024. 761 funds tracked by Wall St. Rank hold XBI as of Q2 2024.

  • Fluent Financial reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2024 after selling out during the quarter.
  • Fluent Financial sold 5,458 State Street SPDR S&P Biotech ETF shares in Q2 2024, an estimated $518K.
  • Fluent Financial first reported a position in State Street SPDR S&P Biotech ETF in Q1 2024 and held it in 1 quarter.
  • Fluent Financial's State Street SPDR S&P Biotech ETF position peaked at $518K in Q1 2024.
  • 761 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2024.

Based on Fluent Financial's 13F filing for Q2 2024, filed 5 Aug 2024.